Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
about
Consequences of metabolic and oxidative modifications of cartilage tissueCombining nano-physical and computational investigations to understand the nature of "aging" in dermal collagenIncreased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes.Pathological significance of mitochondrial glycationGenipin crosslinking of cartilage enhances resistance to biochemical degradation and mechanical wearIncreased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage.Advanced glycation end products: Key players in skin aging?Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Rapamycin Attenuates Age-associated Changes in Tibialis Anterior Tendon Viscoelastic PropertiesProtein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.Aging is not a disease: distinguishing age-related macular degeneration from aging.Articular cartilage changes in maturing athletes: new targets for joint rejuvenation.Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development.Naturally occurring inhibitors against the formation of advanced glycation end-products.Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.Nanophase bone substitute for craniofacial load bearing application: Pilot study in the rodent.Diabetes mellitus and the skin.Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention.Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.Age-related changes of plasma glycosaminoglycans.Perceived Age and Life Style. The Specific Contributions of Seven Factors Involved in Health and Beauty.
P2860
Q28085716-47AD0A3C-B462-4310-9FC7-9A483FE4D480Q33609992-590E22CA-D556-407D-B6C4-9933B1F3A389Q35555571-FDEDD6B7-88DB-4013-94EF-203BE6771983Q35804646-83E13A56-7173-4039-B859-953370C19F15Q36072507-E5E63158-1789-425D-9445-92C7EC86D8D5Q36113229-2852C77E-61DF-4C37-83F7-A52C572DB940Q36245974-A1CA8A3A-D9D5-46B6-AED3-8077667AD969Q36643573-42E574C0-067D-498D-98DD-C2447DBFA3BBQ36644626-32881197-201D-48E0-A7CC-7BECFFC7E562Q36672445-8160837A-3DD8-45F6-8811-822B3EEEEE87Q37000480-F88B15D1-67B6-4DEB-A5CB-66C2C0CBFDD0Q37112969-6F8FE084-D969-41F9-9EE7-A71D694599C1Q37315838-2A1D6D95-FE00-42BD-A687-25ABEF016532Q37417121-DF2E8D16-438C-4A8E-9F7E-1956CBFD905BQ37867110-487492EF-622D-4A5B-8F93-1C5649C25EDAQ37903708-A8B32A9A-4704-41CA-9D5F-9F8663CB5C06Q38700889-0B88715E-9E1A-4725-9F32-72047E77F166Q38757869-15FF7BE6-2098-432E-8500-287077EB240DQ38901757-7BC4C279-D37F-402A-BC41-7D9FA512C5E6Q39368611-D2FF0889-9AA9-476E-A7E0-79806DC847E8Q42099549-6B1C9018-C723-4577-A0D4-C6B63939761EQ46853169-6C081981-2FA4-4E84-98ED-C8B40104FA71Q47143669-1600CDC8-26BA-4ACD-8027-8AF37AF7A3D8
P2860
Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Age-related decrease in suscep ...... vanced glycation end products.
@en
Age-related decrease in suscep ...... vanced glycation end products.
@nl
type
label
Age-related decrease in suscep ...... vanced glycation end products.
@en
Age-related decrease in suscep ...... vanced glycation end products.
@nl
prefLabel
Age-related decrease in suscep ...... vanced glycation end products.
@en
Age-related decrease in suscep ...... vanced glycation end products.
@nl
P2093
P2860
P1476
Age-related decrease in suscep ...... vanced glycation end products.
@en
P2093
F P Lafeber
J M TeKoppele
J W Bijlsma
M J Wenting-Van Wijk
P2860
P304
P356
10.1002/1529-0131(200111)44:11<2562::AID-ART437>3.0.CO;2-1
P577
2001-11-01T00:00:00Z